Lowell Farms Inc
OTC:LOWLF
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
L
|
Lowell Farms Inc
OTC:LOWLF
|
US |
|
C
|
Cobalt Blue Holdings Ltd
OTC:CBBHF
|
AU |
|
R
|
Readboy Education Holding Co Ltd
HKEX:2385
|
CN |
|
A
|
Audax Renovables SA
SWB:54F
|
ES |
|
E
|
Ever Gotesco Resources and Holdings Inc
XPHS:EVER
|
PH |
|
N
|
Noront Resources Ltd
F:NQ1
|
CA |
|
P
|
Plantynet Co Ltd
KOSDAQ:075130
|
KR |
|
Hyundai Electric & Energy Systems Co Ltd
KRX:267260
|
KR |
|
Usinas Siderurgicas de Minas Gerais SA USIMINAS
BOVESPA:USIM5
|
BR |
|
Bunge Global SA
F:Q23
|
US |
|
B
|
Bitcoin Crypto Currency Exchange Corp
OTC:ARSC
|
US |
|
Restart Societa di Investimento Immobiliare Quotata SpA
MIL:RST
|
IT |
|
Liberty Global Ltd
F:3O41
|
BM |
Multiples-Based Value
There is not enough data to reliably calculate the multiples-based value of LOWLF.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Multiples Across Competitors
LOWLF Competitors Multiples
Lowell Farms Inc Competitors
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
L
|
Lowell Farms Inc
OTC:LOWLF
|
285.8k USD | 0 | -0 | -1.2 | -0.9 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
855.1B USD | 13.1 | 41.3 | 27.9 | 29.8 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
574.7B USD | 5.9 | 26.8 | 17.2 | 22 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF | 4.1 | 19.6 | 11.6 | 13.1 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
230.5B GBP | 5.2 | 29.8 | 16.5 | 23.2 | |
| CH |
|
Novartis AG
SIX:NOVN
|
228.1B CHF | 5 | 20.2 | 12.5 | 16.1 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
291.8B USD | 4.4 | 15.7 | 9.7 | 11.9 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
244.4B USD | 105.4 | -83.6 | 386.8 | 970 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.1T DKK | 3.7 | 11.1 | 8.2 | 9.6 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
154.6B USD | 2.5 | 19.9 | 7.7 | 10.2 | |
| UK |
|
GlaxoSmithKline PLC
LSE:GSK
|
86.5B GBP | 2.6 | 15.1 | 8.2 | 10.2 |